全文获取类型
收费全文 | 1634篇 |
免费 | 179篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 41篇 |
妇产科学 | 35篇 |
基础医学 | 300篇 |
口腔科学 | 19篇 |
临床医学 | 156篇 |
内科学 | 409篇 |
皮肤病学 | 96篇 |
神经病学 | 104篇 |
特种医学 | 45篇 |
外科学 | 291篇 |
综合类 | 6篇 |
一般理论 | 1篇 |
预防医学 | 51篇 |
眼科学 | 12篇 |
药学 | 101篇 |
中国医学 | 10篇 |
肿瘤学 | 133篇 |
出版年
2023年 | 10篇 |
2022年 | 20篇 |
2021年 | 102篇 |
2020年 | 53篇 |
2019年 | 71篇 |
2018年 | 91篇 |
2017年 | 64篇 |
2016年 | 86篇 |
2015年 | 68篇 |
2014年 | 97篇 |
2013年 | 89篇 |
2012年 | 122篇 |
2011年 | 139篇 |
2010年 | 72篇 |
2009年 | 61篇 |
2008年 | 109篇 |
2007年 | 119篇 |
2006年 | 103篇 |
2005年 | 107篇 |
2004年 | 76篇 |
2003年 | 59篇 |
2002年 | 54篇 |
2001年 | 9篇 |
2000年 | 3篇 |
1999年 | 8篇 |
1998年 | 9篇 |
1997年 | 10篇 |
1996年 | 1篇 |
1995年 | 5篇 |
1994年 | 2篇 |
1993年 | 2篇 |
1990年 | 1篇 |
1986年 | 1篇 |
排序方式: 共有1823条查询结果,搜索用时 93 毫秒
1.
2.
3.
4.
Laura Tapella Teresa Soda Lisa Mapelli Valeria Bortolotto Heather Bondi Federico A. Ruffinatti Giulia Dematteis Alessio Stevano Marianna Dionisi Simone Ummarino Annalisa Di Ruscio Carla Distasi Mariagrazia Grilli Armando A. Genazzani Egidio D'Angelo Francesco Moccia Dmitry Lim 《Glia》2020,68(3):543-560
Astrocytes perform important housekeeping functions in the nervous system including maintenance of adequate neuronal excitability, although the regulatory mechanisms are currently poorly understood. The astrocytic Ca2+/calmodulin-activated phosphatase calcineurin (CaN) is implicated in the development of reactive gliosis and neuroinflammation, but its roles, including the control of neuronal excitability, in healthy brain is unknown. We have generated a mouse line with conditional knockout (KO) of CaN B1 (CaNB1) in glial fibrillary acidic protein-expressing astrocytes (a stroglial c alcin eurin KO [ACN-KO]). Here, we report that postnatal and astrocyte-specific ablation of CaNB1 did not alter normal growth and development as well as adult neurogenesis. Yet, we found that specific deletion of astrocytic CaN selectively impairs intrinsic neuronal excitability in hippocampal CA1 pyramidal neurons and cerebellar granule cells (CGCs). This impairment was associated with a decrease in after hyperpolarization in CGC, while passive properties were unchanged, suggesting impairment of K+ homeostasis. Indeed, blockade of Na+/K+-ATPase (NKA) with ouabain phenocopied the electrophysiological alterations observed in ACN-KO CGCs. In addition, NKA activity was significantly lower in cerebellar and hippocampal lysates and in pure astrocytic cultures from ACN-KO mice. While no changes were found in protein levels, NKA activity was inhibited by the specific CaN inhibitor FK506 in both cerebellar lysates and primary astroglia from control mice, suggesting that CaN directly modulates NKA activity and in this manner controls neuronal excitability. In summary, our data provide formal evidence for the notion that astroglia is fundamental for controlling basic neuronal functions and place CaN center-stage as an astrocytic Ca2+-sensitive switch. 相似文献
5.
Jose A. Plaza Peter Bonneau Victor Prieto Martin Sangueza Alexander Mackinnon David Suster Carlos Bacchi Bruna Estrozi Dmitry Kazakov Denisa Kacerovska Giovanni Falconieri Saul Suster 《Journal of cutaneous pathology》2016,43(4):313-323
Desmoplastic melanoma (DM) is histologically characterized by a proliferation of spindle melanocytes dispersed in a collagenous stroma that can be mistaken for a variety of neoplasms. The purpose of this study was to analyze 40 cases of DM with a comprehensive panel of immunohistochemical markers (KBA.62, p16, Ezrin, WT‐1, MITF‐1, SOX‐10, CD117, SOX‐2, nestin, PNL2, p75, MART‐1, gp100 and S100p) to obtain a more complete understanding of the potential use of these antibodies in the diagnosis of DM. We found that all cases of DM expressed p16, WT‐1, SOX‐10, nestin and S100p and 95% of cases expressed p75. There was variable expression with Ezrin, SOX‐2, KBA.62, MART‐1 and HMB‐45. Most DMs did not express MITF‐1, PNL2 and CD117. Conditions that may enter in the histologic differential diagnosis of DM, including dermal scars, fibromatosis and dermatofibromas were also studied. Nearly all control cases also stained positive for p16 but were negative for WT1, SOX10, nestin, p75 and S‐100p, as well as for most of the other markers tested. We conclude that a panel of S‐100p, WT1, SOX10, p75 and nestin may constitute the optimal panel with the most sensitive and specific combination of immunostain available for the diagnosis of DM. 相似文献
6.
7.
James B. Ford Dmitry Baturin Tamara M. Burleson Annemie A. Van Linden Yong-Mi Kim Christopher C. Porter 《Oncotarget》2015,6(29):28001-28010
While some children with acute lymphoblastic leukemia (ALL) have excellent prognoses, the prognosis for adults and children with T cell ALL is more guarded. Treatment for T-ALL is heavily dependent upon antimetabolite chemotherapeutics, including cytarabine. Targeted inhibition of WEE1 with AZD1775 has emerged as a strategy to sensitize cancer cells to cytarabine and other chemotherapeutics. We sought to determine if this strategy would be effective for T-ALL with clinically relevant anti-leukemia agents. We found that AZD1775 sensitizes T-ALL cells to several traditional anti-leukemia agents, acting synergistically with cytarabine by enhancing DNA damage and apoptosis. In addition to increased phosphorylation of H2AX at serine 139 (γH2AX), AZD1775 led to increased phosphorylation of H2AX at tyrosine 142, a signaling event associated with promotion of apoptosis over DNA repair. In a xenograft model of T-ALL, the addition of AZD1775 to cytarabine slowed leukemia progression and prolonged survival. Inhibition of WEE1 with AZD1775 sensitizes T-ALL to several anti-leukemia agents, particularly cytarabine. Mechanistically, AZD1775 promotes apoptosis over DNA repair in cells treated with cytarabine. These data support the development of clinical trials including AZD1775 in combination with conventional chemotherapy for acute leukemia. 相似文献
8.
9.
10.
Andrey Morozov Mark Taratkin Eric Barret Nirmish Singla Evgeniy Bezrukov Denis Chinenov Mikhail Enikeev Juan Gomez Rivas Anastasia Shpikina Dmitry Enikeev 《Andrologia》2020,52(10):e13789
Irreversible electroporation is a treatment option used for focal therapy. In this systematic review, we summarise data on irreversible electroporation outcomes in patients with localised prostate cancer. We performed a literature search in 3 databases and included articles with own data on irreversible electroporation results in patients with localised prostate cancer. Primary outcome was procedure efficacy measured as the absence of cancer in the treatment area on the follow-up biopsy. Secondary outcomes were the absence of prostate cancer recurrence in the treatment area on MRI, out-of-field recurrence, complications and functional outcomes (erectile function and micturition). In-field recurrence rate was 0%–39% and out-field 6.4%–24%. In all studies, PSA level decreased: twice lower than baseline after 4 weeks and by 76% after 2 years. Most of the authors noted sexual and urinary toxicity during the first half year after surgery. However, functional outcomes recovered to baseline after 6 months with mild decrease in sexual function. Complication rates after irreversible electroporation were 0%–1% of Clavien–Dindo III and 5%–20% of Clavien–Dindo I–II. Irreversible electroporation has promise oncological outcomes, rate of post-operative complications and minimal-to-no effects on erectile and urinary function. However, medium and long-term data on cancer-specific and recurrence-free survival are still lacking. 相似文献